| Literature DB >> 19994845 |
Marina Kritsanida1, Prokopios Magiatis, Alexios-Leandros Skaltsounis, Youyi Peng, Peng Li, Lawrence P Wennogle.
Abstract
The bis-indole alkaloid indirubin and its analogues bear a very interesting natural pharmacophore. They are recognized mainly as kinase inhibitors, but several other activities make them possible candidates for preclinical studies. Based on the previously reported activity of 7-bromoindirubin-3'-oxime and its derivatives, the synthesis of indirubins bearing a heterocyclic nitrogen atom at position 7 was carried out. Herein, we report the first synthesis of 7-azaindirubin-3'-oxime (12) as well as its antiproliferative activity against 57 cancer cell lines and its inhibitory activity against a series of kinases. 7-Azaindirubin (10) and its 3'-oxime derivative (12) showed reduced activity as kinase inhibitors in comparison with other known indirubin derivatives, but antiproliferative activity with a best GI(50) value of 0.77 microM.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19994845 DOI: 10.1021/np9003905
Source DB: PubMed Journal: J Nat Prod ISSN: 0163-3864 Impact factor: 4.050